Defibrillator challenges for the new millennium: The marriage of device and patient - Making and maintaining a good match

Journal of Cardiovascular Electrophysiology

Volumn 11, Issue 6, 2000, Pages 697-709

  Friedman, Paul A ^c   Glikson, Michael ^a   Stanton, Marshall S ^b  

^a SHEBA MEDICAL CENTER   (Israel)

^b MEDTRONIC INC   (United States)

^c MAYO CLINIC   (United States)

Author keywords

Defibrillator; Device device interaction; Follow up; Implantation; Indications

Indexed keywords

ADULT; AGED; ARTICLE; CASE REPORT; CONGESTIVE HEART FAILURE; DEFIBRILLATOR; DEVICE; ELECTROCARDIOGRAM; FEMALE; FOLLOW UP; HEART ARREST; HEART ARRHYTHMIA; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; LONG QT SYNDROME; MALE; PACEMAKER; PATIENT SELECTION; PRIORITY JOURNAL; SURGICAL APPROACH; TREATMENT INDICATION;

EID: 0034047911     PISSN: 10453873     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8167.2000.tb00034.x     Document Type: Article

References (49)

1. 1. Mirowski M, Reid P, Mower M, et al: Termination of malignant ventricular arrhythmias with an implanted automatic defibrillator in human beings. N Engl J Med 1980:303:322-324.
2. 2. Gregoratos G, Cheitlin MD, Conill A, et al: ACC/AHA guidelines for implantation of cardiac pacemakers and antiarrhythmia devices: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Pacemaker Implantation). J Am Coll Cardiol 1998:31:1175-1209.
3. 3. Zipes DP, Roberts D: Results of the international study of the implantable pacemaker cardioverter-defibrillalor. A comparison of epicardial and endocardial lead systems. The Pacemaker-Cardioverter-Defibrillator Investigators. Circulation 1995;92:59-65.
4. 4. Moss AJ, Hall WJ, Cannom DS, et al: Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med 1996;335:1933-1940.
5. 5. Anonymous: A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. N Engl J Med 1997;337:1576-1583.
6. 6. Friedman PA, Stanton MS: The pacer-cardioverter-defibrillator: Function and clinical experience. J Cardiovasc Electrophysiol 1995;6:48-68.
7. 7. Stanton MS, Hayes DL, Munger TM, et al: Consistent subcutaneous prepectoral implantation of a new implantable cardioverter defibrillator. Mayo Clin Proc 1994;69:309-314.
8. 8. Buxton A: Multicenter Unsustained Tachycardia Trial (MUSTT). Presentations at American College of Cardiology Scientific Sessions, 1999 and North American Society of Pacing and Electrophysiology Scientific Session, 1999.
9. 9. Spirito P, Seidman CE, McKenna WJ, et al: The management of hypertrophic cardiomyopathy. N Engl J Med 1997;336:775-785.
10. 10. Primo J, Geelen P, Brugada J, et al: Hypertrophic cardiomyopathy: Role of the implantable cardioverter-defibrillator. J Am Coll Cardiol 1998:31:1081-1085.
11. 11. Maron BJ, Shen WK, Link MS, et al: Efficacy of the implantable cardioverter-defibrillators for the prevention of sudden death in hypertrophic cardiomyopathy. N Engl J Med 2000:342:365-373.
12. 12. Moss AJ: Clinical management of patients with the long QT syndrome: Drugs, devices, and gene-specific therapy. PACE 1997; 20:2058-2060.
13. 13. Friedman P, Rasmussen M, Grice S, et al: Defibrillation thresholds are increased by right-sided implantation of totally transvenous implantable cardioverter defibrillators. PACE 1999;22:1186-1192.
14. 14. Gold MR, Peters RW, Johnson JW, et al: Complications associated with pectoral cardioverter-defibrillator implantation: Comparison of subcutaneous and submuscular approaches. Worldwide Jewel Investigators. J Am Coll Cardiol 1996;28:1278-1282.
15. 15. Heil J, Lin Y, Derfus D, et al: Impact of ICD electrode position on transvenous defibrillation thresholds. PACE 1995;18:873.
16. 16. Reddy RK, Bardy GH: Unipolar pectoral defibrillation systems. PACE 1997;20:600-606.
17. 17. Brady P, Friedman PA, Trusty JM, et al: High failure rate for an epicardial implantable cardioverter-defibrillator lead: Implications for long-term follow-up of patients with an implantable cardioverter-defibrillator. J Am Coll Cardiol 1998;31:616-622.
18. 18. Luria D, Rasmussen MJ, Hammill SC, et al: Frequency and mode of detection of nonthoracotomy implantable defibrillator lead failure. PACE 1999;22:705.
19. 19. Luria D, Chugh S, Lexvold N, et al: High rate of long term endovascular lead failure with abdominally placed implantable defibrillators. (Abstract) Circulation 1999;100:1-568.
20. 20. Glikson M, Trusty JM, Grice SK, et al: A stepwise testing protocol for modern implantable cardioverter defibrillator systems to prevent pacemaker-implantable cardioverter-defibrillator interactions. Am J Cardiol 1999;83:360-366.
21. 21. Lavergne T, Daubert JC, Chauvin M, et al: Preliminary clinical experience with the first dual chamber pacemaker defibrillator. PACE 1997;20:182-188.
22. 22. Glikson M, Trusty JM, Grice SK, et al: Importance of pacemaker noise reversion as a potential mechanism of pacemaker-ICD interactions. PACE 1998;21:1111-1121.
23. 23. Epstein LM, Byrd CL, Wilkoff BL, et al: Initial experience with larger laser sheaths for the removal of transvenous pacemaker and implantable defibrillator leads. Circulation 1999;100:516-525.
24. 24. Lickfett L, Wolpert L, Jung C, et al: Inappropriate implantable defibrillator discharge caused by a retained pacemaker lead fragment. J Interven Card Electrophysiol 1999;3:163-167.
25. 25. Friedman PA, Stein KM, Wharton JM, et al: Reduced atrial fibrillation burden with prompt treatment by an implantable arrhythmia management device-evidence of reverse remodelling. Circulation 1999;100:1-69.
26. 26. Andersen HR, Nielsen JC, Thomsen PE, et al: Long-term follow-up of patients from a randomised trial of atrial versus ventricular pacing for sick-sinus syndrome. Lancet 1997;350:1210-1216.
27. 27. Best PJ, Hayes DL, Stanton MS: The potential usage of dual chamber pacing in patients with implantable cardioverter defibrillators. PACE 1999;22:79-85.
28. 28. Gras D, Mabo P, Tang T, et al: Multisite pacing as a supplemental treatment of congestive heart failure: Preliminary results of the Medtronic Inc. In Sync study. PACE 1998;21:2249-2255.
29. 29. Stein K, Hess M, Hannon C, et al: Atrial arrhythmias in ICD recipients: Incidence and efficacy of atrial antitachycardia pacing. (Abstract) PACE 1999;22:824.
30. 30. Swerdlow CD, Gunderson BD, Gillberg JM, et al: Discrimination of concurrent atrial and ventricular tachyarrhythmias from rapidly conducted atrial arrhythmias by dual chamber ICDs. (Abstract) PACE 1999;22:775.
31. 31. Swerdlow CD, Ahern T, Chen PS, et al: Underdetection of ventricular tachycardia by algorithms to enhance specificity in a tiered-therapy cardioverter-defibrillator. J Am Coll Cardiol 1994;24:416-424.
32. 32. Brugada J, Mont L, Figueiredo M, et al: Enhanced detection criteria in implantable defibrillators. J Cardiovasc Electrophysiol 1998;9:261-268.
33. 33. Swerdlow CD, Sheth MV, Olson WH: Clinical performance of a pattern-based dual chamber algorithm for discrimination of ventricular and supraventricular arrhythmias. (Abstract) PACE 1998; 21:800.
34. 34. Kuhlkamp V, Dornberger V, Mewis C, et al: Clinical experience with the new detection algorithms for atrial fibrillation of a defibrillator with dual chamber sensing and pacing. J Cardiovasc Electrophysiol 1999;10:905-915.
35. 35. Gillis AM, Wyse DC, Connolly SJ, et al: Atrial pacing periablation for prevention of paroxysmal atrial fibrillation. Circulation 1999; 99:2553-2558.
36. 36. Garrigue S, Barold SS, Cazeau S, et al: Prevention of atrial arrhythmias during DDD pacing by atrial overdrive. PACE 1998; 21:1751-1760.
37. 37. Lerman B, Stein K, Markowitz S: Worldwide clinical experience with the model 7250 Jewel AF dual chamber arrhythmia management device. PACE 1998;21:872.
38. 38. Ayers GM, Griffin JC: The future role of defibrillators in the management of atrial fibrillation. Curr Opin Cardiol 1997;12:12-17.
39. 39. Heisel A, Jung J: The atrial defibrillator: A stand-alone device or part of a combined dual-chamber system? Am J Cardiol 1999;83: 218D-226D.
40. 40. Chauhan A, Grace AA, Newell SA, et al: Early complications after dual chamber versus single chamber pacemaker implantation. PACE 1994;17:2012-2015.
41. 41. Auricchio A, Hartung W, Geller C, et al: Clinical relevance of stored electrograms for implantable cardioverter-defibrillator (ICD) troubleshooting and understanding of mechanisms for ventricular tachyarrhythmias. Am J Cardiol 1996;78:33-41.
42. 42. Brady PA, Friedman PA, Trusty JM, et al: High failure rate for an epicardial implantable cardioverter-defibrillator lead: Implications for long-term follow-up of patients with an implantable cardioverter-defibrillator [published erratum appears in J Am Coll Cardiol 1998:32:555]. J Am Coll Cardiol 1998:31:616-622.
43. 43. Korte T, Jung W, Spehl S, et al: Incidence of ICD lead related complications during long-term follow-up: Comparison of epicardial and endocardial electrode systems. PACE 1995;18: 2053-2061.
44. 44. Lehmann MH, Saksena S: Implantable cardioverter defibrillators in cardiovascular practice: Report of the policy conference of the North American Society of Pacing and Electrophysiology. PACE 1991;14:969-979.
45. 45. Wieckhorst A, Buchwald A, Unterberg C: On the necessity of the invasive predischarge test after implantation of a cardioverter-defibrillator. Am J Cardiol 1998:81:933-935.
46. 46. Glikson M, Luria D, Friedman PA, et al: Are routine arrhythmia inductions necessary in patients with pectoral implantable cardioverter defibrillators? J Cardiovasc Electrophysiol 2000;11:127-135.
47. 47. Olsovsky MR, Pelini MA, Shorofsky SR, et al: Temporal stability of defibrillation thresholds with an active pectoral lead system. J Cardiovasc Electrophysiol 1998;9:240-244.
48. 48. Luria D, Glikson M, Hammill S, et al: Stability of long-term defibrillation thresholds in patients with nonthoracotomy implantable defibrillators. Cardiac Arrhythmias, 6th International Workshop, Venice, Italy, 1999, Volume 1, Springer Verlag Italia.
49. 49. Schaumann A, von zur Muhlen F, Herse B, et al: Empirical versus tested antitachycardia pacing in implantable cardioverter defibrillators: A prospective study including 200 patients. Circulation 1998;97:66-74.